The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rosuvastatin/Ezetimibe KRKA 10 mg/10 mg Film-Coated Tablets



KRKA, d.d., Novo mestoPA1347/108/001

Main Information

Trade NameRosuvastatin/Ezetimibe KRKA 10 mg/10 mg Film-Coated Tablets
Active SubstancesRosuvastatin calcium
Ezetimibe
Dosage FormFilm-coated tablet
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/108/001

Group Information

ATC CodeC10BA06 rosuvastatin and ezetimibe

Status

License statusAuthorised
Licence Issued06/01/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0111-017-009
Interchangeable List DocumentPDF of Interchangeable List
« Back